Evaluation of API ID 32C® and VITEK-2® to identify Candida dubliniensis

Diagnostic Microbiology and Infectious Disease

Volumn 50, Issue 3, 2004, Pages 219-221

  Cárdenes Perera, Carmen Delia ^a   Torres Lana, Álvaro ^a,b   Alonso Vargas, Rocío ^c   Moragues Tosantas, María Dolores ^c   Pontón San Emeterio, José ^c   Quindós Andrés, Guillermo ^c   Arévalo Morales, María Pilar ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL ENZYME; LACTIC ACID; PHOSPHATASE;

ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; DATA BASE; DIAGNOSTIC TEST; ENZYME ASSAY; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; NONHUMAN; PRIORITY JOURNAL;

AUTOMATION; CANDIDA; CANDIDIASIS; HUMANS; MYCOLOGICAL TYPING TECHNIQUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY;

EID: 8444224609     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2004.06.010     Document Type: Article

References (18)

1. Al Mosaid A., Sullivan D.J., Coleman D.C. Differentiation of Candida dubliniensis from Candida albicans on Pal's Agar. J Clin Microbiol. 41:2003;4787-4789
2. Alonso-Vargas R., Garaizar J., Pontón J., Quindós G. Utility of random amplified polymorphic DNA in the discrimination between Candida albicans and Candida dubliniensis. Rev Iberoam Micol. 17:2000;10-13
3. Alves S.H., Milan E.P., de Laet Sant'Ana P., Oliveira L.O., Santurio J.M., Colombo A.L. Hypertonic sabouraud broth as a simple and powerful test for Candida dubliniensis screening. Diagn Microbiol Infect Dis. 43:2002;85-86
4. Bikandi J., San Millán R., Moragues M.D., Cebas G., Coleman D.C., Quindós G., Pontón J. Rapid identification of Candida dubliniensis by indirect immunofluorescence. J Clin Microbiol. 36:1998;2428-2433
5. Coleman D.C., Sullivan D., Bennett D.E., Moran G.P., Barry H.J., Shanley D.B. Candidiasis the emergence of a novel species, Candida dubliniensis. AIDS. 11:1997;557-567
6. Coleman D.C., Rinaldi M.G., Haynes K.A., Rex J.H., Summerbell R.C., Anaissie E.J., Li A., Sullivan D.J. Importance of Candida species other than Candida albicans as opportunistic pathogens. Med Mycol. 36:(Suppl 1):1998;156-165
7. Ellepola A.N., Hurst S.F., Elie C.M., Morrison C.J. Rapid and unequivocal differentiation of Candida dubliniensis from other Candida species using species-specific DNA probes comparison with phenotypic identification methods. Oral Microbiol Immunol. 18:2003;379-388
8. Gilfillan G.D., Sullivan D.J., Haynes K., Parkinson T., Coleman D.C., Gow N.A.R. Candida dubliniensis Phylogeny and putative factors. Microbiology. 144:1998;829-838
9. Graf B., Adam T., Zill E., Göbe U.B. Evaluation of the VITEK 2 system for rapid identification of yeast and yeast-like organisms. J Clin Microbiol. 38:2000;1782-1785
10. Gutiérrez J., Morales P., González M.A., Quindós G. Candida dubliniensis, a new fungal pathogen. J Basic Microbiol. 42:2002;207-227
11. Moran G.P., Sullivan D.J., Henman M.C., McCreary C.E., Harrington B.J., Shanley D.B., Coleman D.C. Antifungal drug susceptibility of oral Candida dubliniensis isolates from HIV-infected and non-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother. 41:1997;617-623
12. Pfaller M.A., Messer S.A., Gee S., Joly S., Pujol C., Sullivan D.J., Coleman D.C., Soll D.R. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J Clin Microbiol. 37:1999;870-872
13. Pincus D.H., Coleman D.C., Pruitt W.R., Padhye A.A., Salkin I.F., Geimer M., Bassel A., Sullivan D.J., Clarke M., Hearn V. Rapid Identification of C. dubliniensis with Commercial Yeast Identification Systems. J Clin Microbiol. 37:1999;3533-3539
14. Polacheck I., Strahilevitz J., Sullivan D., Donnelly S., Salkin I.F., Coleman D.C. Recovery of Candida dubliniensis from non-human Immunodefiency Virus-infected patients in Israel. J Clin Microbiol. 38:2000;170-174
15. Quindós G., Carrillo-Muñoz A.J., Arévalo M.P., Salgado J., Alonso-Vargas R., Rodrigo J.M., Ruesga M.T., Valverde A., Pemán J., Cantón E., Martin-Mazuelos E., Pontón J. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents. Chemotherapy. 46:2000;395-401
16. Sebti A., Kiehn T., Perlin D., Chaturvedi V., Wong M., Doney A., Park S., Sepkowitz K.A. Candida dubliniensis at a Cancer Center. Clin Infec Dis. 32:2001;1034-1038
17. Sullivan D.J., Westerneng T.J., Haynes K.A., Bennett D.E., Coleman D.C. Candida dubliniensis sp. nov. phenotypic and molecular charcaterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology. 141:1995;1507-1521
18. Sullivan D., Haynes K., Bille J., Boerlin P., Rodero L., Lloyd S., Henman M., Coleman D. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiciency virus-infected individuals. J Clin Microbiol. 35:1997;960-964